Humira®

 
Active substance Adalimumab
Holder AbbVie sa/nv
Status Closed
Indication Active enthesitis-related arthritis in patients, 6 years of age and older, who have had an inadequate response to, or who are intolerant to, conventional therapy
Public documents Approbation
Information for the patient
Informed consent
Last update 17/07/2017
   
 
 
   
Last updated on 13/09/2024